Top 10 Healthcare Devices and Supplies Capital Raises and Investors in the U.S. – January 1st to 31st, 2026
Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me.
PIPE
- Anteris Technologies, cutting-edge medical devices that restore healthy heart function, received $90 million of development capital from Medtronic.
- Nuwellis, medical device used in ultrafiltration therapy that removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics, received $3.07 million of development capital from investors.
Merger/Acquisition
- Integrity Orthopaedics, rotator cuff repair device that redefines the landscape of soft tissue repair, was acquired by Smith & Nephew, for $450 million.
- Nalu Medical, neurostimulation implant that provides long-term relief for patients with intractable chronic nerve pain, was acquired by Boston Scientific for $600 million.
Later Stage VC
- Corfigo, cardiac devices for the ablation of atrial and ventricular tissue from an epicardial approach, raised $2.39 million of Series A-2 funding from investors, putting the company’s pre-money valuation at $17.61 million.
- Omega Ophthalmics, surgically implanted lenses that create a space for augmented reality inside the eye, raised $320,000 of venture funding from investors.
Early Stage VC
- Immersive Hearing Technologies, sound simulation platform that revolutionizes the demonstration experience within audiology clinics, raised venture funding from Keyhorse Capital.
- LymeAlert, at-home tick testing kit that helps people identify potential Lyme disease risk quickly after a tick is found on a person or animal, raised venture funding from Fortify Ventures.
Seed Round
- ChronicleBio, decentralized research ecosystem that advances the understanding and treatment of complex neuroimmune disorders, raised $5.36 million of seed funding from Tarsadia Investments and other investors.
- Xella Health, at-home diagnostic testing for early detection and monitoring of women’s reproductive health conditions, raised $3.7 million of pre-seed funding in a deal led by Precursor Ventures.
#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcare #medtech #medicaltechnology #healthcaredevices #healthcaresupplies
Tamara Williams
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
